Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
Globe Newswire•04/08/2026•08:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.